Xospata (gilteritinib) - Astellas
Vanflyta (quizartinib) - Daiichi Sankyo
sorafenib - Generic mfg.
Rydapt (midostaurin) - Novartis
crenolanib besylate (ARO-002) - AROG
https://library.ehaweb.org/eha/2022/eha2022-congress/357432/david.quintela.gilteritinib.and.quizartinib.in.relapsed.refractory.28r.r29.acute.html?f=menu%3D6%2Abrowseby%3D8%2Asortby%3D2%2Amedia%3D3%2Ace_id%3D2233%2Aot_id%3D26840%2Amarker%3D1752%2Afeatured%3D17676
 
David Quintela; Mireia Morgades; Alfons Serrano; Marta Cervera; Amaia Balerdi; Marina Díaz-Beyá; Montserrat Arnan; Anna Garrido; Rosa Coll; Mar Tormo; Javier López-Marin; Brayan Merchan; Sara Garcia; Marisol Casado; Antonia Sampol; Jordi Esteve; David Martínez-Cuadrón; Jordi Sierra; Miguel Ángel Sanz; Josep Maria Ribera; Pau Montesinos; Susana Vives
 
May 13, 2022
 
Prev Next